Artax Biopharma
PrivateLast Round
Early Stage
VC
May 5, 2026
Est. Valuation
$51.35M
Total Funding Raised
$44M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Artax Biopharma is a biotechnology company that develops small molecule drugs designed to treat autoimmune and inflammatory diseases by targeting T cell-mediated immune responses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artax Biopharma Comparables
Compare Artax Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revolo Biotherapeutics | 71% | |
| Johnson & Johnson | 71% | |
| Bristol Myers Squibb | 70% | |
Artax Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | May 5, 2026 | ||||
| Convertible Debt | Aug 6, 2024 | ||||
| Series C | May 11, 2022 | ||||
| Series B Extension | Jun 4, 2020 | ||||
| Series B | Sep 22, 2015 |
Key People
Founding team and executive leadership
Artax Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Columbus Ventures | Convertible Debt |
| A. M. Pappas & Associates | Series B |
| Advent Life Sciences | Convertible Debt, Series C, Series B |
| Columbus Venture Partners | Convertible Debt, Series C, Series B Extension |
| Sound Bioventures | Convertible Debt, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
$19M raised in early stage VC round.
- Mar 7, 2025
Presented preclinical data at the 2025 American Academy of Dermatology Annual Meeting.
Artax Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Artax Biopharma's valuation, stock price, and market status.